A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome

  • Maria Juarez
  • , Nieves Diaz
  • , Geoffrey I. Johnston
  • , Saba Nayar
  • , Andrew Payne
  • , Eric Helmer
  • , Dionne Cain
  • , Paulette Williams
  • , Valerie Devauchelle-Pensec
  • , Benjamin A. Fisher
  • , Roberto Giacomelli
  • , Jacques Eric Gottenberg
  • , Giuliana Guggino
  • , Marika Kvarnström
  • , Xavier Mariette
  • , Wan Fai Ng
  • , José Rosas
  • , Juan Sánchez Bursón
  • , Giovanni Triolo
  • , Francesca Barone
    • Simon J. Bowman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science